(Q40411164)

20 September 2017

Evaluation of the molecular mechanisms involved in the gain of function of a Li-Fraumeni TP53 mutation (English)

1 reference

20 September 2017

6

1 reference

20 September 2017

10

1 reference

20 September 2017

Giorgio Cantelli-Forti

12

object named as

Giorgio Cantelli-Forti

0 references

Silvia Soddu

object named as

Silvia Soddu

8

0 references

Domenico Ribatti

9

object named as

Domenico Ribatti

1 reference

20 September 2017

Silvia Capponcelli

1

1 reference

20 September 2017

Elena Pedrini

2

1 reference

20 September 2017

Maria Antonietta Cerone

3

1 reference

20 September 2017

Valeria Corti

4

1 reference

20 September 2017

Silvia Fontanesi

5

1 reference

20 September 2017

Angela Bachi

7

1 reference

20 September 2017

Lee J Helman

11

1 reference

20 September 2017

Giorgio Cantelli-Forti

12

1 reference

20 September 2017

Luca Sangiorgi

13

1 reference

20 September 2017

1 August 2005

1 reference

20 September 2017

1 reference

20 September 2017

26

1 reference

20 September 2017

2

1 reference

20 September 2017

94-103

1 reference

Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?

20 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20192

Two Li-Fraumeni syndrome families with novel germline p53 mutations: loss of the wild-type p53 allele in only 50% of tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20192

No defect in G1/S cell cycle arrest in irradiated Li-Fraumeni lymphoblastoid cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20192

Synergistic effect of peroxiredoxin II antisense on cisplatin-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20192

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20192

7 January 2021

Gapped BLAST and PSI-BLAST: a new generation of protein database search programs

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20192

7 January 2021

Preoperative therapy versus immediate surgery in nonmetastatic osteosarcoma.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20192

7 January 2021

Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20192

7 January 2021

Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20192

7 January 2021

Wild-type p53 gene transfer is not detrimental to normal cells in vivo: implications for tumor gene therapy

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20192

7 January 2021

Requirement of vascular integrin alpha v beta 3 for angiogenesis

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20192

7 January 2021

p53 is involved in the differentiation but not in the differentiation-associated apoptosis of myoblasts

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20192

7 January 2021

Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20192

7 January 2021

Proteome study of human cerebrospinal fluid following traumatic brain injury indicates fibrin(ogen) degradation products as trauma-associated markers

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20192

7 January 2021

Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20192

7 January 2021

Gain of function mutations in p53.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20192

7 January 2021

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20192

7 January 2021

The Li-Fraumeni syndrome: an inherited susceptibility to cancer

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20192

7 January 2021

Coexpression of adult T-cell leukemia-derived factor, a human thioredoxin homologue, and human papillomavirus DNA in neoplastic cervical squamous epithelium.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20192

7 January 2021

Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20192

7 January 2021

Tumor spectrum analysis in p53-mutant mice

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20192

7 January 2021

Mutation of the p53 tumor suppressor gene in spontaneously occurring osteosarcomas of the dog

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20192

7 January 2021

Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-alpha.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20192

7 January 2021

Mutation and cancer: statistical study of retinoblastoma

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20192

7 January 2021

Accumulating active p53 in the nucleus by inhibition of nuclear export: a novel strategy to promote the p53 tumor suppressor function

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20192

7 January 2021

Cancer. p53, guardian of the genome

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20192

7 January 2021

Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20192

7 January 2021

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20192

7 January 2021

p53 status and the efficacy of cancer therapy in vivo

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20192

7 January 2021

Strand scission of DNA by bound adriamycin and daunorubicin in the presence of reducing agents

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20192

7 January 2021

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20192

7 January 2021

Nuclear localization and signalling activity of phosphoinositidase C beta in Swiss 3T3 cells

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20192

7 January 2021

Expression and growth-promoting effect of adult T-cell leukemia-derived factor. A human thioredoxin homologue in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20192

7 January 2021

Identification of yeast DNA topoisomerase II mutants resistant to the antitumor drug doxorubicin: implications for the mechanisms of doxorubicin action and cytotoxicity

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20192

7 January 2021

Possible involvement of thioredoxin reductase as well as thioredoxin in cellular sensitivity to cis-diamminedichloroplatinum (II).

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20192

7 January 2021

Nuclear exclusion of wild-type p53 in immortalized human retinoblastoma cells

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20192

7 January 2021

Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20192

7 January 2021

Fibroblasts from Li-Fraumeni patients are resistant to low dose-rate irradiation

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20192

7 January 2021

A detailed study of loss of heterozygosity on chromosome 17 in tumours from Li – Fraumeni patients carrying a mutation to the TP53 gene

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20192

7 January 2021

Germline TP53 mutations and Li-Fraumeni syndrome

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20192

7 January 2021

Spontaneous necrosis in osteosarcomas

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20192

7 January 2021

Analysis of centrosome abnormalities and angiogenesis in epidermal-targeted p53172H mutant and p53-knockout mice after chemical carcinogenesis: evidence for a gain of function

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20192

7 January 2021

Hot-spot mutants of p53 core domain evince characteristic local structural changes.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20192

7 January 2021

ProFound: an expert system for protein identification using mass spectrometric peptide mapping information

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20192

7 January 2021

Identifiers

DOI

10.1002/HUMU.20192

1 reference

20 September 2017

1 reference